Holen Sie sich die Stockscreener-App
427.62
5.60%
22.68
Handel nachbörslich:
429.73
2.11
+0.49%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$404.94
Offen:
$406.31
24-Stunden-Volumen:
3.67M
Relative Volume:
1.34
Marktkapitalisierung:
$161.42B
Einnahmen:
$42.90B
Nettoeinkommen (Verlust:
$6.52B
KGV:
25.08
EPS:
17.05
Netto-Cashflow:
$6.72B
1W Leistung:
+2.30%
1M Leistung:
+7.47%
6M Leistung:
-25.58%
1J Leistung:
-21.74%
1-Tages-Spanne:
$405.15
$428.99
1-Wochen-Bereich:
$403.36
$428.99
52-Wochen-Spanne:
$385.46
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Vergleichen Sie TMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Thermo Fisher Scientific Inc. Surges 39.52% in Trading Volume Ranking 45th in Market Activity - AInvest
Behind the Scenes of Thermo Fisher Scientific's Latest Options Trends - Nasdaq
A Preview Of Thermo Fisher Scientific's Earnings - 富途牛牛
Canada Oncology Market Outlook to 2033 - GlobeNewswire Inc.
Thermo Fisher Skyrockets 4.7% Intraday, What's Fueling This Record-Breaking Rally? - AInvest
What analysts say about Thermo Fisher Scientific Inc. stockConsistent double returns - jammulinksnews.com
U.S. Biomarkers Market Forecast 2025-2034 Featuring Analysis of Roche, Merck, Thermo Fisher Scientific, QIAGEN and Other Industry Leaders - Yahoo Finance
Electronic Laboratory Notebook Market is Dazzling Worldwide | Thermo Fisher Scientific, BenchlingMajor Giants - openPR.com
Thermo Fisher Scientific Inc. Stock Analysis and ForecastExplosive earnings growth - jammulinksnews.com
Thermo Fisher Scientific Inc.: Company Analysis Report - AInvest
Thermo Fisher Scientific Company Analysis Report | Key Milestones/History, Product Offerings, Technologies, Major Applications and End-user Industries - Yahoo Finance
Thermo Fisher (TMO) Reports Q2: Everything You Need To Know Ahead Of Earnings - FinancialContent
Thermo Fisher Scientific's Trading Volume Hits 11.12 Billion, Ranks 72nd Amid Market Decline - AInvest
Thermo Fisher Scientific accelerates precision oncology research - Scientist Live
India In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, Danaher - Yahoo Finance
Mass Spectrometry Company Evaluation Report 2025 | Agilent, Thermo Fisher, and Waters Lead with Robust Portfolios, Strategic Expansions, and Innovation-Driven Growth - Yahoo Finance
What drives Thermo Fisher Scientific Inc. stock priceSkyrocketing profit margins - jammulinksnews.com
Thermo Fisher Scientific’s (TMO) Dividend: Steady Payouts in a Growing Market - MSN
Is Thermo Fisher Scientific Inc. a good long term investmentHigh-impact investment strategies - Autocar Professional
Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi - Insider Monkey
Thermo Fisher acquires Sanofi’s steriles manufacturing site in US - MSN
Thermo Fisher Scientific's Q2 2025 Earnings: Navigating Near-Term EPS Pressures With a High-Innovation Engine - AInvest
Thermo Fisher Scientific's Q2 2025 Earnings Outlook: Assessing Growth Resilience Amid EPS Declines and Strategic Momentum in Key Verticals - AInvest
Thermo Fisher acquires Sanofi's New Jersey manufacturing site - MSN
Lobbying Update: $400,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Quiver Quantitative
Thermo Fisher Scientific Inc. (NYSE:TMO) Q1 2025 Earnings Call Transcript - MSN
Thermo Fisher Scientific Trading Volume Ranks 84th Amid Price Target Cut - AInvest
Thermo Fisher (TMO) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates - MSN
Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know - Yahoo Finance
13 Best Long Term Low Volatility Stocks to Buy Now - Insider Monkey
Pharma Contract Research Organization (CRO) Services Market to Cross USD 36.66 Billion in 2025, Expanding at a CAGR of 10.04% - GlobeNewswire Inc.
TMO to Report Q2 Earnings: Analytical Instruments Segment in Focus - TradingView
How the Digital Genome Market Will Evolve by 2032Growth, - openPR.com
Thermo Fisher and Sanofi Expand Strategic Partnership to Enable US Drug Manufacturing - CHEManager
Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche - GlobeNewswire
Thermo Fisher Scientific Ranks 98th in Trading Volume with 10.51 Billion as Stock Price Surges 2.08 - AInvest
Thermo Fisher Acquires Sanofi’s Ridgefield Facility to Produce Essential Medicines - geneonline.com
Thermo Fisher Scientific's Options: A Look at What the Big Money is Thinking - Nasdaq
Thermo Fisher Agrees to Acquire Sanofi’s Steriles Manufacturing Site - Genetic Engineering and Biotechnology News
Thermo Fisher Scientific, SAMRC, DSTI launch new scientific training facility - Engineering News
Thermo Fisher to Acquire Sanofi's Ridgefield Sterile Manufacturing Site - PharmiWeb.com
Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing - BioSpace
Thermo Fisher to acquire Sanofi’s steriles manufacturing site in US to produce critical medicines - BioSpectrum Asia
Thermo Fisher Scientific Inc. Ranks 83rd in Trading Volume with 11.51 Billion Shares Exchanged Amid Acquisition News and Strong Financial Results - AInvest
Thermo Fisher and Sanofi Expand Partnership to Enable Manufacturing - New Jersey Business Magazine
Thermo Fisher Scientific price target lowered to $550 by TD Cowen - Investing.com
Sanofi, Thermo Fisher announce partnership to boost US manufacturing - WFMZ.com
Thermo Fisher bolsters US fill-finish capacity with Sanofi plant purchase - Fierce Pharma
Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):